FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657

B.F. Goemans, C.M. Zwaan, J. Cloos, D. de Lange, A.H. Loonen, D Reinhardt, K. Hahlen, B.E.S. Gibson, U. Creutzig, G.J.L. Kaspers

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1302-1307
JournalLeukemia research
Issue number10
Publication statusPublished - 2010

Cite this